KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Debt Ratio (2016 - 2026)

Gilead Sciences filings provide 17 years of Debt Ratio readings, the most recent being 0.42 for Q4 2025.

  • On a quarterly basis, Debt Ratio fell 6.69% to 0.42 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.42, a 6.69% decrease, with the full-year FY2025 number at 0.42, down 6.69% from a year prior.
  • Debt Ratio hit 0.42 in Q4 2025 for Gilead Sciences, down from 0.43 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.45 in Q4 2024 to a low of 0.39 in Q4 2021.
  • Median Debt Ratio over the past 5 years was 0.42 (2022), compared with a mean of 0.42.
  • Biggest five-year swings in Debt Ratio: dropped 14.42% in 2021 and later increased 12.57% in 2024.
  • Gilead Sciences' Debt Ratio stood at 0.39 in 2021, then increased by 1.67% to 0.4 in 2022, then rose by 0.7% to 0.4 in 2023, then grew by 12.57% to 0.45 in 2024, then decreased by 6.69% to 0.42 in 2025.
  • The last three reported values for Debt Ratio were 0.42 (Q4 2025), 0.43 (Q3 2025), and 0.45 (Q2 2025) per Business Quant data.